Storage & Stability Protocols
This medication works by binding to and activating the GLP-1 receptor, a receptor commonly targeted in other treatments of type 2 diabetes
Whether you're looking for personalized guidance, assistance with medication access, or support in adopting healthier habits, our monthly membership offers a comprehensive solution to help you thrive on your wellness journey
Synthesised via solid-phase peptide synthesis, it consists of the sequence Tyr-hGH, which preserves part of the original hormones secondary structure but operates independently of classical hGH receptor binding
What they found: No serious adverse events triggered by AOD-9604 The most frequent side effects: headache (~5 %), occasional fatigue, at the same frequency as placebo No changes in IGF-1 levels, glycemia, blood pressure, heart rate No signals of cardiovascular, hepatic or renal toxicity Safety profile comparable to placebo Why it matters: From a safety perspective, AOD-9604 is one of the safest peptides in the clinical registry